Enovix Corporation vs DENTSPLY SIRONA Inc — how do they compare? Enovix Corporation trades at $4.7 (market cap $1.11B), while DENTSPLY SIRONA Inc trades at $13.73 (market cap $2.68B). The key difference: DENTSPLY SIRONA Inc is far larger — about 2.4× Enovix Corporation's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Enovix Corporation pays none. Which is the better fit depends on your goals.
| ENVX | XRAY | |
|---|---|---|
Market Cap | $1.11B | $2.68B |
Sector | Technology | Health |
52-Week High | $15.93 | $16.85 |
52-Week Low | $4.84 | $9.64 |
Enterprise Value | $1.13B | $4.83B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $4.855, down 4.05% today amid bearish technical signals. The company shows strong revenue growth potential with recent earnings beats but operates at a significant loss, reflected in a -499.64% net margin. Positive sentiment is driven by analyst consensus with a $12.75 price target and recent operational hires from Apple, though cash flow remains negative as production scales.
Outlook hinges on successful manufacturing ramp-up and smartphone battery qualification. High execution risk and cash burn present challenges, but leadership in silicon-anode technology offers long-term upside if commercial targets are met. Investors face volatility but potential reward from current discounted levels.
Dentsply Sirona (XRAY) trades at $12.70, down 0.63% with bearish profitability metrics including negative net income margin and ROE. The stock shows mixed technical signals with bullish moving averages but overbought RSI levels. Recent earnings have consistently missed expectations, though the company maintains a 48.93% gross margin and is expanding its US distribution network with new partnerships and AI-enabled product launches.
While analyst consensus leans Hold with a $13.33 price target, the stock faces significant fundamental challenges including declining revenue, negative earnings, and rising debt-to-asset ratios. Near-term catalysts include the Q2 2026 earnings report and continued execution of the Return-to-Growth plan, but investors should weigh the high valuation multiples against persistent profitability concerns.
Trailing returns across standard periods
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →